02.08.2011 • News

Wacker Chemie Q2 Profit Rises

Wacker Chemie reported that net income for second quarter reached €142.7 million compared to €135.4 million in the year-ago period, resulting in earnings per share of €2.87 versus €2.71 last year.

Second quarter sales increased 10% to €1.33 billion from €1.20 billion for the same period last year mainly due to the higher sales volumes generated by sustained customer demand.

Looking forward, Wacker expects full-year sales and earnings to rise in 2011. group sales are forecast to top €5 billion. EBITDA for fiscal 2011 is anticipated to exceed last year's figure of €1.19 billion.

Company

Wacker Chemie

Hanns-Seidel-Platz 4
81737 Munich
Germany

Company contact

I am interested in:

an offer
a callback
detailed information

Your request

salutation first name last name

country phone email

Please note our data protection information for the contact form.

Virtual Event

Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.